Evaluation of an I177L gene-based five-gene-deleted African swine fever virus as a live attenuated vaccine in pigs

African swine fever (ASF) is a highly contagious disease of domestic and wild pigs caused by the African swine fever virus (ASFV). The current research on ASF vaccines focuses on the development of naturally attenuated, isolated, or genetically engineered live viruses that have been demonstrated to...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yingnan, Xie, Zhenhua, Li, Yao, Song, Yingying, Di, Dongdong, Liu, Jingyi, Gong, Lang, Chen, Zongyan, Wu, Jinxian, Ye, Zhengqin, Liu, Jianqi, Yu, Wanqi, Lv, Lu, Zhong, Qiuping, Tian, Chuanwen, Song, Qingqing, Wang, Heng, Chen, Hongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769145/
https://www.ncbi.nlm.nih.gov/pubmed/36378022
http://dx.doi.org/10.1080/22221751.2022.2148560
Descripción
Sumario:African swine fever (ASF) is a highly contagious disease of domestic and wild pigs caused by the African swine fever virus (ASFV). The current research on ASF vaccines focuses on the development of naturally attenuated, isolated, or genetically engineered live viruses that have been demonstrated to produce reliable immunity. As a result, a genetically engineered virus containing five genes deletion was synthesized based on ASFV Chinese strain GZ201801, named ASFV-GZΔI177LΔCD2vΔMGF. The five-gene-deleted ASFV was safe and fully attenuated in pigs and provides reliable protection against the parental ASFV strain challenge. This indicates that the five-gene-deleted ASFV is a potential candidate for a live attenuated vaccine that could control the spread of ASFV.

Ejemplares similares